Table 2. Example of preventable and non-preventable adverse drug reactions.
Preventability Criteria | Example | |
---|---|---|
Preventable ADR | Non-Preventable ADR | |
Reaction occurred in a patient who previously had a documented prior allergic/reaction to the current causative drug. | Rash developed after administration of flucloxacillin in a patient with a documented allergy to penicillins [23, 43]. | Rash developed after administration of flucloxacillin in a patient with no documented allergy to penicillins. |
Reaction occurred due to any errors in medication process, including error during prescribing, dispensing, and administration. | Myopathy developed in a statin user who was recently prescribed systemic azole antifungal (Fail to identify drug-drug interaction) [23, 65]. | Reaction developed without indication of possible drug-drug interaction. |
Exacerbations of asthma related with NSAID use (Contraindication overlooked) [67]. | Reaction occurred despite appropriate selection of medication for patients’ condition. | |
Rectal haemorrhage in a dabigatran user >75 years old related with incorrect dosage. Patient was given maximum recommended dosage (220mg/day), while in the SmPC of dabigatran, patient ≥ 75 years should receive lower dose (150 mg/day) [68] | Reaction occurred despite appropriate selection of dosage for patients’ condition. | |
Hypoglycemic event due to medication administration error [69]. | Reaction occurred despite appropriate dosing administration. | |
Required therapeutic drug monitoring or other necessary laboratory tests were not (adequately) performed. | Bleeding occurred in warfarin user with inadequate frequency of INR monitoring (led to elevated INR, e.g., INR > 4.5) [66]. | Bleeding occurred despite the target INR had been achieved. |
Symptomatic hyperkalaemia in spironolactone user related with inadequate potassium monitoring [70] | Reaction occurred despite adequate laboratory monitoring and regimen adjustment. |
NSAID: non-steroidal antiinflammatory drugs. SmPC: summary of product characteristic.